We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-56.03%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$2.12M
AUM Growth
-$152M
Cap. Flow
-$45.4M
Cap. Flow %
-2,141.05%
Top 10 Hldgs %
100%
Holding
21
New
–
Increased
–
Reduced
–
Closed
20

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$6.66M
2
BDX icon
Becton Dickinson
BDX
+$6.46M
3
MDRX
Veradigm Inc. Common Stock
MDRX
+$5.72M
4
MCK icon
McKesson
MCK
+$4.78M
5
COLL icon
Collegium Pharmaceutical
COLL
+$4.13M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRM
1
DELISTED
Streamline Health Solutions
STRM
$2.12M 100%
328,725
– –
ANGO icon
2
AngioDynamics
ANGO
$634M
– –
-475,000
Closed -$3.47M
ATRC icon
3
AtriCure
ATRC
$2.62B
– –
-40,000
Closed -$1.75M
BDX icon
4
CALL
Becton Dickinson
BDX
$50.8B
– –
-65,000
Closed -$16.8M
BDX icon
5
Becton Dickinson
BDX
$50.8B
– –
-25,000
Closed -$6.46M
CERS icon
6
Cerus
CERS
$516M
– –
-650,000
Closed -$1.05M
COLL icon
7
Collegium Pharmaceutical
COLL
$787M
– –
-185,000
Closed -$4.13M
DXCM icon
8
CALL
DexCom
DXCM
$33.2B
– –
-100,000
Closed -$9.33M
MCK icon
9
McKesson
MCK
$107B
– –
-11,000
Closed -$4.78M
OEF icon
10
CALL
iShares S&P 100 ETF
OEF
$20.5B
– –
-50,000
Closed -$4.43M
PHR icon
11
Phreesia
PHR
$669M
– –
-215,000
Closed -$4.02M
SIBN icon
12
SI-BONE Inc
SIBN
$821M
– –
-50,000
Closed -$1.06M
SNY icon
13
Sanofi
SNY
$106B
– –
-30,000
Closed -$1.61M
SPY icon
14
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-150,000
Closed -$64.1M
TCMD icon
15
Tactile Systems Technology
TCMD
$502M
– –
-239,222
Closed -$3.36M
TEVA icon
16
CALL
Teva Pharmaceuticals
TEVA
$42.7B
– –
-100,000
Closed -$1.02M
THC icon
17
Tenet Healthcare
THC
$21.3B
– –
-20,000
Closed -$1.32M
VTRS icon
18
CALL
Viatris
VTRS
$19.4B
– –
-600,000
Closed -$5.92M
VTRS icon
19
Viatris
VTRS
$19.4B
– –
-675,000
Closed -$6.66M
MDRX
20
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-200,000
Closed -$2.63M
MDRX
21
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-435,000
Closed -$5.72M

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Tamarack Advisers held 21 positions worth $2.12M, down 99% from $154M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tamarack Advisers withdrew a net $45.4M in Q4 2023, closing 20 positions. Its most notable exit was Viatris, an estimated $6.66M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 32% a quarter earlier.

  • Tamarack Advisers fully exited Viatris in Q4 2023, selling an estimated $6.66M.
  • Tamarack Advisers's ten largest holdings make up 100% of its $2.12M portfolio in Q4 2023.
  • Tamarack Advisers opened 0 new positions and closed 20 in Q4 2023.
  • Tamarack Advisers's portfolio value fell 99% quarter-over-quarter to $2.12M.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.